- US-listed companies
- OCULAR THERAPEUTIX, INC
- Balance sheet
OCULAR THERAPEUTIX, INCOCUL
Market cap
$2.3B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 37 | 31 | 33 | 42 | 61 | 56 | 230 | 166 | 104 | 198 | 394 |
| Marketable securities, current | 37 | 74 | 35 | - | - | - | - | - | - | - | - |
| Total cash & short-term investments | 75 | 105 | 68 | 42 | 61 | 56 | 230 | 166 | 104 | 198 | 394 |
| Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 3 | 12 | 21 | 21 | 26 | 32 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Total current assets | 76 | 107 | 70 | 43 | 56 | 60 | 246 | 191 | 130 | 232 | 441 |
| Property, plant and equipment, net | 2 | 3 | 3 | 10 | 10 | 10 | 8 | 7 | 10 | 12 | 9 |
| Total non-current assets | 2 | 3 | 5 | 12 | 17 | 19 | 16 | 14 | 20 | 20 | 17 |
| Total assets | 78 | 110 | 75 | 55 | 73 | 79 | 262 | 205 | 149 | 252 | 458 |
| Accounts payable | 1 | 2 | 2 | 4 | 3 | 3 | 3 | 5 | 5 | 4 | 4 |
| Total current liabilities | 6 | 5 | 8 | 13 | 9 | 12 | 27 | 26 | 31 | 35 | 41 |
| Total non-current liabilities | 14 | 15 | 15 | 16 | 28 | 70 | 159 | 91 | 83 | 126 | 101 |
| Total liabilities | 19 | 21 | 23 | 29 | 37 | 82 | 186 | 117 | 114 | 161 | 143 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained earnings | -89 | -129 | -174 | -237 | -297 | -384 | -539 | -546 | -617 | -698 | -891 |
| Stockholders' equity | 59 | 90 | 52 | 26 | 36 | -4 | 76 | 88 | 35 | 91 | 315 |
| Working capital |